- Home
- ASBP vs NIKI Comparison
ASBP vs NIKI Comparison
Compare ASBP & NIKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.25
N/A
Current Price
$8.93
Company Overview
Basic Information| Metric | ASBP | NIKI |
|---|---|---|
| Founded | 2021 | N/A |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 6.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ASBP | NIKI |
|---|---|---|
| Price | $7.25 | $8.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 64.1K | 27.9K |
| Earning Date | 04-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $7.80 |
| 52 Week High | $8.17 | $8.82 |
Technical Indicators
Market Signals| Indicator | ASBP | NIKI |
|---|---|---|
| Relative Strength Index (RSI) | 61.43 | N/A |
| Support Level | $0.17 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.60 | 0.00 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 67.70 | 0.00 |
Price Performance
Historical Comparison ASBP
NIKI
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.